This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
DRD1 · Western blot design guide
Design a Western Blot for DRD1
Real validated DRD1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-DRD1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Last reviewed: May 2026 · Scientific review: Boster Bio technical team
DRD1 Western Blot Experimental Design Guide
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before running
| Expected band | ~49.3 kDa | |
| Gel | 10–12% | |
| Negative control | siRNA / KO lysate |
Important caveats
Reasons your observed band may differ from the expected size.
| PTM | Glycosylated | |
| Caveat | Glycosylation increases apparent size | |
| Regulation | LPS-induced | |
| Isoform | 1 isoform(s) |
Section 1
Real Curated DRD1 Western Blot Protocols
Literature-validated Western blot parameters for DRD1 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | SH-SY5Y cells stably expressing FLAG-tagged DRD1 |
| Transfer | electroblotting (buffer/time/voltage not mentioned) |
| Membrane | Protan nitrocellulose (GE Healthcare Life Sciences) |
| Blocking | 3% low-fat milk in 1X PBS-Tween 0.05% |
| Primary antibody | 1:2000 (anti-DRD1, D2944, Sigma-Aldrich) |
| Primary incubation | 16 h at 4°C |
| Secondary antibody | 1:2500 (goat anti-mouse) or 1:5000 (goat anti-rabbit) - not specified which for DRD1 |
| Detection | enhanced chemiluminescence (Pierce Biotechnology) |
Section 2
What Is the Expected DRD1 Western Blot Band Size?
DRD1 has a 49.3 kDa predicted backbone that typically runs somewhat higher and more diffuse on blots due to N-glycosylation at Asn5 and its multi-pass membrane topology.
| A single band around 49-55 kDa | Matches the 49.3 kDa predicted backbone with only a modest upward shift from its lone N-glycosylation site |
| Band appears broad or diffuse rather than sharp, spanning roughly 50-60 kDa | Heterogeneous N-linked glycosylation at Asn5 on the mature receptor produces glycoform microheterogeneity |
| A doublet with a lower, tighter band alongside a higher, more diffuse band | Reflects distinct maturation pools, an ER-resident core-glycosylated immature form versus a plasma-membrane-trafficked, fully glycosylated mature form |
| Slightly faster migration under non-reducing versus reducing sample buffer | The Cys96-Cys186 disulfide bond stabilizes a compact extracellular-loop fold that runs marginally faster when left intact |
| No smaller cleavage fragment below the main band | DRD1 has no annotated signal peptide or propeptide, so the translated chain is not proteolytically processed and full length is the mature form |
| Signal present in a membrane-enriched fraction but weak or absent in a cytosolic fraction | Consistent with DRD1 being a multi-pass membrane protein located at the plasma membrane and ER membrane rather than a soluble cytosolic protein |
💡Expected DRD1 appearanceExpect a single, moderately diffuse band around 49-55 kDa in membrane-containing lysates, reflecting the 49.3 kDa predicted backbone plus modest mass added by N-glycosylation at Asn5, sometimes resolving as a doublet from ER versus plasma-membrane glycoforms.
| Predicted backbone mass (49.3 kDa, 446 aa) | Sets the baseline size expected under fully reduced, deglycosylated conditions |
| N-glycosylation at Asn5 | Adds carbohydrate mass and heterogeneity, shifting and broadening the band above the 49.3 kDa backbone |
| Disulfide bond Cys96-Cys186 | Stabilizes a compact extracellular-loop conformation that can shift mobility slightly when reduction is incomplete, though it is intrachain and does not generate a dimer-sized species |
| Multi-pass membrane topology (plasma membrane and ER membrane, multiple transmembrane helices) | Hydrophobic transmembrane helices bind SDS poorly, commonly causing this GPCR to migrate anomalously or smear/aggregate rather than resolve as one sharp band |
| ER membrane versus plasma membrane trafficking maturation | The immature ER pool with core glycosylation runs lower and tighter than the mature plasma-membrane pool with complex glycosylation, producing a size gradient rather than one fixed band |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | DRD1 has low, tissue-restricted native expression and is not reliably detected outside receptor-enriched tissue | Confirm the assay with a known-positive tissue such as brain lysate and use a detergent-based lysis buffer suited to multi-pass membrane proteins |
| Band higher than expected | N-glycosylation at Asn5 combined with SDS-resistant aggregation typical of hydrophobic multi-pass membrane proteins | Treat lysate with PNGase F to confirm the glycan contribution and avoid boiling samples, heating at 37-50C instead to limit aggregation |
| Broad smear instead of sharp band | Heterogeneous glycoforms from the single N-glycosylation site plus partial membrane-protein aggregation | Deglycosylate with PNGase F or neuraminidase/glycosidase panel and use fresh reducing agent with gentle heating rather than boiling |
| Multiple bands | Coexisting ER core-glycosylated immature and plasma-membrane complex-glycosylated mature pools, or incomplete reduction of the Cys96-Cys186 disulfide | Repeat with PNGase F treatment to collapse glycoform bands and ensure fresh DTT or beta-mercaptoethanol for complete reduction |
| Weak or no signal | Standard aqueous lysis buffers extract this multi-pass membrane protein poorly | Use a membrane-protein-compatible detergent buffer, increase total protein loaded, and include a validated positive control tissue such as brain |
Experiment evidence
Western blot images showing DRD1 band
PA1571 · DRD1
← swipe / scroll for more images →
Real WB data behind the band-size expectations in this section.
Sample controls for DRD1 Western blot
🧪For positive controls for DRD1 in Western blot, you can use a DRD1-overexpressing cell line (e.g., HEK293 or CHO cells transiently or stably transfected with DRD1), since Human Protein Atlas expression data is not available for this receptor to identify a native positive tissue.
Positive control: DRD1-transfected HEK293 cells
Negative control: untransfected/parental HEK293 cells (no HPA negative-tissue data available)
Loading controls: Run GAPDH and β-actin antibody blots alongside a total-protein stain (e.g., stain-free gel, Ponceau S, or REVERT) to confirm equal loading.
⚠️Feasibility: With no HPA expression data available, native tissue controls cannot be confidently identified, and as a low-abundance multi-pass membrane GPCR (ER/cell membrane) DRD1 is prone to weak endogenous signal, so a transfected overexpression system with a matched untransfected line is the more feasible control strategy.
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|
Section 3
Advanced DRD1 Western Blot Tips
Deeper troubleshooting and optimisation questions for DRD1, answered from its protein features.
Why might DRD1 migrate above its 49 kDa predicted mass?
DRD1 carries one N-glycosylation site and a palmitoylation site, both of which add mass and alter SDS-PAGE mobility. Multi-pass transmembrane GPCRs also retain residual structure in SDS, causing anomalous migration. Expect bands anywhere from 50-75 kDa rather than exactly 49.3 kDa; treat this as normal receptor behavior, not a sizing error.
How does glycosylation affect DRD1 band interpretation?
DRD1 has one predicted N-glycosylation site. Because glycan occupancy varies between tissues and cell lines, this can produce a diffuse or slightly heterogeneous band rather than one sharp line. Treat this smearing as expected receptor heterogeneity, not degradation; PNGase F treatment can collapse the band to confirm glycosylation is the cause.
What blocking buffer works best for DRD1 blots?
Since DRD1 is a glycosylated membrane protein, milk-based blockers, which themselves contain glycoproteins, can raise nonspecific lectin-like background. Use a BSA-based blocking buffer instead of nonfat milk for cleaner results, particularly when probing with glycan-sensitive detection reagents or when band clarity near the glycosylated region matters.
What transfer method to use for DRD1 Western blot?
DRD1 is a multi-pass transmembrane GPCR and transfers poorly with standard rapid protocols. Use wet transfer with low-methanol (10 percent) transfer buffer and PVDF membrane, extending transfer time to fully mobilize this hydrophobic receptor out of the gel rather than leaving it trapped in the matrix.
Which loading control suits DRD1 membrane fraction quantitation?
Because DRD1 localizes to the cell membrane and ER membrane, normalize membrane-enriched lysates to a membrane-resident loading control such as Na+/K+-ATPase rather than cytosolic GAPDH, since membrane extraction efficiency can differ from whole-cell lysate controls and skew quantitation if mismatched.
Why do extra higher-molecular-weight DRD1 bands appear?
DRD1 interacts with DRD2 and DRD3 and can form receptor heterodimers, and it contains one disulfide bond. Under non-reducing conditions or incomplete denaturation, these interactions can produce higher-molecular-weight bands corresponding to dimers or heterodimers running alongside the expected monomer band.
Do I need reducing agents to resolve DRD1 monomer?
Yes. DRD1 has one disulfide bond that can stabilize dimers or aggregates if samples are not fully reduced. Include DTT or beta-mercaptoethanol in sample buffer, and avoid excessive boiling of membrane protein samples, which can promote aggregation of this multi-pass transmembrane receptor.
Boster reagents
Best DRD1 Western Blot Antibodies
BosterBio's DRD1 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Real WB data
Anti-Dopamine Receptor D1/DRD1 Antibody Picoband®
Cat # PA1571
For DRD1 Western blotting, Boster's PA1571 antibody is the top recommended choice: extensively validated with published citations and orthogonally confirmed across rat testis, rat brain, U87, and HeLa lysates, delivering consistent, specific signal and reliable cross-tissue reproducibility for confident target detection.
Which to pick: Only one DRD1 antibody is catalogued: PA1571. Select it by default; its listing includes an actual Western blot validation image across rat testis, rat brain, U87, and HeLa lysates, confirming specificity and cross-sample reproducibility.
Source: BosterBio DRD1 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.
References
- UniProt Consortium. UniProt entry P21728.
- Human Protein Atlas. DRD1 tissue expression.